Multi-component biological transport systems

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S078020, C424S078030, C424S078070, C424S078170, C424S134100, C530S303000, C530S350000, C530S387100

Reexamination Certificate

active

07807780

ABSTRACT:
Compositions and methods are provided that are useful for the delivery of therapeutic agents, including nucleic acids. The compositions can be prepared with components useful for targeting the delivery of the compositions as well as imaging components.

REFERENCES:
patent: 4434228 (1984-02-01), Swann
patent: 4816568 (1989-03-01), Hamilton, Jr. et al.
patent: 5252713 (1993-10-01), Morgan, Jr. et al.
patent: 5420105 (1995-05-01), Gustavson et al.
patent: 5512547 (1996-04-01), Johnson et al.
patent: 5607691 (1997-03-01), Hale et al.
patent: 5629020 (1997-05-01), Leone-Bay et al.
patent: 5709861 (1998-01-01), Santiago et al.
patent: 5744166 (1998-04-01), Illum
patent: 5747641 (1998-05-01), Frankel et al.
patent: 5756468 (1998-05-01), Johnson et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 5795587 (1998-08-01), Gao et al.
patent: 5804604 (1998-09-01), Frankel et al.
patent: 5877278 (1999-03-01), Zuckermann et al.
patent: 5985434 (1999-11-01), Qin et al.
patent: 5989545 (1999-11-01), Foster et al.
patent: 6217912 (2001-04-01), Park et al.
patent: 6280937 (2001-08-01), Luo et al.
patent: 6306423 (2001-10-01), Donovan et al.
patent: 6312708 (2001-11-01), Donovan
patent: 6383509 (2002-05-01), Donovan et al.
patent: 6413941 (2002-07-01), Garnett et al.
patent: 6495663 (2002-12-01), Rothbard et al.
patent: 6506399 (2003-01-01), Donovan
patent: 6511676 (2003-01-01), Boulikas
patent: 6585993 (2003-07-01), Donovan et al.
patent: 6593292 (2003-07-01), Rothbard et al.
patent: 6610820 (2003-08-01), Bonny
patent: 6645501 (2003-11-01), Dowdy
patent: 6669951 (2003-12-01), Rothbard et al.
patent: 6670322 (2003-12-01), Goodnough et al.
patent: 6680301 (2004-01-01), Berg et al.
patent: 6683049 (2004-01-01), Aoki et al.
patent: 6692911 (2004-02-01), Pack et al.
patent: 6696038 (2004-02-01), Mahato et al.
patent: 6730293 (2004-05-01), Rothbard et al.
patent: 6759387 (2004-07-01), Rothbard et al.
patent: 6831059 (2004-12-01), Donovan
patent: 6866856 (2005-03-01), Lu et al.
patent: 6896886 (2005-05-01), Aoki et al.
patent: 6974578 (2005-12-01), Aoki et al.
patent: 7008924 (2006-03-01), Yan et al.
patent: 7056656 (2006-06-01), Rana et al.
patent: 7060498 (2006-06-01), Wang
patent: 2001/0024716 (2001-09-01), Chen et al.
patent: 2002/0009491 (2002-01-01), Rothbard et al.
patent: 2002/0131965 (2002-09-01), Rothbard et al.
patent: 2003/0022831 (2003-01-01), Rothbard et al.
patent: 2003/0032593 (2003-02-01), Wender et al.
patent: 2003/0086256 (2003-05-01), Rothbard et al.
patent: 2003/0104622 (2003-06-01), Robbins et al.
patent: 2003/0118598 (2003-06-01), Hunt
patent: 2003/0138437 (2003-07-01), Hunt
patent: 2003/0162719 (2003-08-01), Rothbard et al.
patent: 2003/0165567 (2003-09-01), Mixson
patent: 2003/0185788 (2003-10-01), Rothbard et al.
patent: 2003/0215395 (2003-11-01), Yu et al.
patent: 2003/0220480 (2003-11-01), Bonny
patent: 2003/0229034 (2003-12-01), Waugh et al.
patent: 2003/0236214 (2003-12-01), Wolff et al.
patent: 2004/0009180 (2004-01-01), Donovan
patent: 2004/0009469 (2004-01-01), Apt et al.
patent: 2004/0013687 (2004-01-01), Simpson
patent: 2004/0033241 (2004-02-01), Donovan
patent: 2004/0037853 (2004-02-01), Borodic
patent: 2004/0127556 (2004-07-01), Lu et al.
patent: 2004/0147443 (2004-07-01), Renault
patent: 2004/0161405 (2004-08-01), Rothbard et al.
patent: 2004/0186045 (2004-09-01), Rothbard et al.
patent: 2004/0192754 (2004-09-01), Shapira et al.
patent: 2004/0220100 (2004-11-01), Waugh et al.
patent: 2004/0220386 (2004-11-01), Steward et al.
patent: 2004/0247614 (2004-12-01), Dorr et al.
patent: 2004/0247623 (2004-12-01), Cady
patent: 2005/0074461 (2005-04-01), Donovan
patent: 2005/0112146 (2005-05-01), Graham
patent: 2005/0175636 (2005-08-01), Donovan
patent: 2005/0196414 (2005-09-01), Dake et al.
patent: 2005/0232966 (2005-10-01), Hughes et al.
patent: 2005/0238667 (2005-10-01), Hunt
patent: 2005/0239705 (2005-10-01), Dake et al.
patent: 2006/0018931 (2006-01-01), Taylor
patent: 2006/0024331 (2006-02-01), Fernandez-Salas
patent: 2006/0040882 (2006-02-01), Chen
patent: 2007/0077259 (2007-04-01), Dake et al.
patent: 1180524 (2002-02-01), None
patent: WO 92/07871 (1992-05-01), None
patent: WO 94/04686 (1994-03-01), None
patent: WO 96/11712 (1996-04-01), None
patent: WO 97/40854 (1997-11-01), None
patent: WO 98/19710 (1998-05-01), None
patent: WO 98/22610 (1998-05-01), None
patent: WO 98/24596 (1999-05-01), None
patent: WO 99/24596 (1999-05-01), None
patent: WO 99/42901 (1999-08-01), None
patent: WO 00/24419 (2000-05-01), None
patent: WO 00 24419 (2000-05-01), None
patent: WO 00/32764 (2000-06-01), None
patent: WO 00/34308 (2000-06-01), None
patent: WO 01/13957 (2001-03-01), None
patent: WO 01/62297 (2001-08-01), None
patent: WO 02 07773 (2002-01-01), None
patent: WO 02/07773 (2002-01-01), None
patent: WO 02/065986 (2002-08-01), None
patent: WO 02/067917 (2002-09-01), None
patent: WO 02/069930 (2002-09-01), None
patent: WO 03/049772 (2003-06-01), None
patent: WO 03 072049 (2003-09-01), None
patent: WO 2006/005910 (2006-01-01), None
Wu et al (J. Biol. Chem 262(10): 4429-4432, 1987).
GenBank Accession No. M77788 (2005).
Cristiano et al (Proc. Nat. Acad. Sci. USA 90: 11548-11552).
Puls et al (Gene Therapy 6: 1774-1778, 1999).
http://www.genlantis.com/catalog/product—line.cfm?product—family—key=13&product—line—key=54, retrieved from the internet on Sep. 2, 2005.
1998 Promega Catalog, pp. 262-265.
Kabanov et al (Adv. Drug Del. Rev 30: 49-610, 1998).
Console et al., “Antennapedia and HIV Transcription (TAT) Promote Endocytosis of High Molecular Weight Cargo Upon Binding to Cell Surface Clycosaminoglycans”, J. Biol. Chem. vol. 278, No. 37, pp. 35109-35114.
Crosland et al., “Detection of Sparse Botulinum Toxin A Binding Sites using Fluorescent Latex Microspheres”, J. of Histotechnology, vol. 22, No. 2, pp. 113-115, Jun. 1999.
Schantz et al., “Properties and Use of Botulinum Toxin and Other Microbial Neurotoxins in Medicine”. Microbiological Reviews, Col. 56, No. 1, Mar. 1992, pp. 80-89.
Schwartz et al., “Peptide-Mediated Cellular Delivery” Curr. Opin. Mol. Ther. vol. 2, No. 2 pp. 162-167, 2000.
Shalaby, “Polymers for Augmenting Botulinum Vaccine Efficiency”—Abstract.
Urbanova et al., “Noncovalent interaction of peptides with porphyrins in aqueous solution: conformational study using vibrational CD spectroscopy”, Biopolymers (Peptide Science), col. 60, pp. 307-316, 2001.
1992 Sigma Catalog, p. 1745.
Green, M. “Mutational analysis of HIV-1 TAT minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression”, Cell, 58:215-223.
“AIDS, Use of HIV-1 TAT, to target and/or activate antigen-presenting cells, and/or to deliver cargo molecules” from http://pharmalicensing.com/public/outlicensing/view/3766 (2001).
Printout of website for “botulinum cream” from http://www.ebigchina.com/ebcps/4/pd/82305.html.
http:www.genlantis.com/catalog/product—line.cfm?product—family—key=13&product—line—key=54, retrieved from the internet on Sep. 2, 2005.
U.S. Appl. No. 11/816,602, filed Aug. 17, 2007, Dake, et al.
U.S. Appl. No. 10/591,486, filed Jun. 18, 2007, Dake, et al.
U.S. Appl. No. 10/591,732, filed Sep. 1, 2006, Dake, et al.
U.S. Appl. No. 10/591,485, filed Sep. 1, 2006, Waugh et al.
U.S. Appl. No. 11/954,885, filed Dec. 12, 2007, Waugh, et al.
U.S. Appl. No. 11/955,076, filed Dec. 12, 2007, Waugh, et al.
Blanes-Mira et al., Identification of Snare complex Modulators that Inhibit Exocytosis from an Alpha-Helix-Constrained Combinatorial Library,Biochem. J., vol. 375(1), pp. 159-166, Oct. 1, 2003.
Blanes-Mira et al., Small peptides after the N-Terminus domain of Snap25 Inhibit Snare complex assembly and regulated exocytosis,J. of Neurochem., vol. 88(1), pp. 124-135, Jan. 2004.
Blanes-Mira et al., A Synthetic Hexapeptide Argireline) with Antiwrinkle Activity,Int'l J. of Cosmetic Science, vol. 24(5), pp. 303-310, 2002.
Fisher et al., Matrix Sialoprote

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Multi-component biological transport systems does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multi-component biological transport systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-component biological transport systems will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4236969

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.